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Background: Chronic Obstructive Pulmonary Disease (COPD) ranks third as cause of mortality and disability-adjusted
life years (DALY) worldwide and also in Italy it imposes a huge health, social and economic load. Early symptoms of
COPD are often disregarded by patients and physicians, spirometry is underutilized, and the diagnosis is delayed till the
disease has reached a distinct severity level. Despite the availability of various guidelines, the behavior of health workers
involved in the management of COPD is still rather unlike. These considerations are the reason why in October 2013
AIMAR (Interdisciplinary Scientific Association for Research in Lung Disease) devised and organized a “Third Consensus
Conference”, aimed at pointing out the standards of suitability for COPD management. In this context three important
topics of discussion were identified: early and more widespread diagnosis, management of acute and subacute phases,
long-term assistance to chronic patients.
Methods: The procedure recommended by the Italian Health Superior Institute (ISS) for Consensus Conferences
organization was applied. The Conference was structured in three sessions, each dealing with one of the above
mentioned topics and including a short update of the subject-matter and presentation, discussion and voting of
some statements with a choice ranging from total agreement to total disagreement or no knowledge. The results
of voting were eventually recorded in the document, reviewed by an independent jury, that forms the substance
of this paper.
Results: The essential role of spirometry, the need for distinguish between different COPD phenotypes, and the
obligatoriness to base on the blood gas analysis findings the long-term oxygen therapy, were largely agreed, as
well as the need for interventions aimed at decreasing the rate of acute exacerbations. More specific topics like
the use of noninvasive ventilation, recognizing the factors affecting outcome and mortality, the choice of
pharmacological and non pharmacological treatments in COPD patients led to lively discussing, but they did not
always reach the total agreement, probably because of insufficient familiarity with these problems and of
diversities in organization and instruments availability. The chronic respiratory assistance was treated with
particular regard to smoking cessation, whose implementation is still insufficient. Many doubts rose due to
uncertainty, lack of ability and standardization of procedures, insufficient institutional support, and difficulties to
realize a network for assistance to chronic patients.
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Conclusions: The results of this Third Consensus Conference revealed some certainties and many doubts and
diversities of view also on topics whose importance is well demonstrated in scientific literature. Thus, there is still a
long distance to cover before reaching a suitable standardization of COPD management and such situation urges
the need for improving not only the health professional’s operativeness but also the organizational support by
competent institutions. In this context some initiatives organized by AIMAR in cooperation with other respiratory
scientific societies and patients’ associations are going on.
Keywords: Acute and chronic therapy, Acute exacerbations, COPD, Diagnosis, Guidelines, Management, Smoking,
Spirometry, Standards of suitabilityBackground
Disability and mortality due to noncommunicable dis-
eases are still a relevant worldwide problem, and a 25%
reduction of the mortality due to these diseases is the
target established by 2025 by United Nations (UN) and
World Health Organisation (WHO) in individuals aged
30–70 years [1-3]. Among noncommunicable diseases
Chronic Obstructive Pulmonary Disease (COPD) ranks
third as cause of mortality and disability-adjusted life
years (DALY) [4]. Also in Italy respiratory diseases are
the third cause of mortality [5] and COPD, presumed af-
fecting 5% or more of adult population, imposes a con-
siderable health, social, and economic burden [6-9], all
the more that the few reported data likely underestimate
the real prevalence of the disease, thus leading to its
undertreatment [10]. In fact, COPD is often diagnosed
at an advanced severity stage, when acute exacerbations,
emergency unit accesses, and the need of pharmacologic
and non-pharmacologic costly treatments frequently
occur. Early COPD symptoms are often overlooked by
patients or their physicians because considered an un-
avoidable consequence of smoking instead as important
signs of an incipient disease that more or less rapidly
will become irreversible, progressive, and severely disab-
ling [11-16]. Also spirometry, a critical examination for
COPD diagnosis and/or confirmation is underutilized
[17], and not rarely the diagnosis is established on clin-
ical grounds only [18]. Despite the availability of several
international and national COPD guidelines [6,7,19], the
behavior of medical and non-medical health workers in
the management of chronic respiratory diseases (CRD)
is still very dissimilar. It is thus mandatory to improve
the suitability of diagnostic and therapeutic interven-
tions, that should be effective, safe, and efficient in order
to decrease the burden imposed by these diseases. On
the other hand, also the organization of the National
Health Service (NHS) should be updated and adapted to
the needs of CRD, since the assistance is still mainly
based on hospital ground, while WHO recommends a
patient-centered continuity of assistance [20]. In this
context is really mandatory that all persons who at what-
ever level are involved in the management of CRD bescientifically competent and professionally trained to ob-
serve well-defined organizational arrangements in order
to conduct at best their tasks. Such an exigency refers
not only to the patient’s care, but also to an efficient
organization of institutional and administrative func-
tions. In this respect, the regional compartmentation of
NHS makes difficult, if not impossible, to uniform the
management of CRD, also because useful pilot experi-
ences experimented in some Italian regions are not al-
ways followed in other regions as would be hoped for.
Based on the above considerations, AIMAR (Interdiscip-
linary Scientific Association for Research in Lung Disease),
after organizing two similar conferences in 2007 [21] and
2010 [22], in 2013 devised and organized the Third Con-
sensus Conference (CC) in Respiratory Medicine with a
new format aimed at involving all health framework en-
gaged in the management of CRD, from the general prac-
titioner to district and hospital specialists, administrative
directors, together with experts of health organization and
management, besides patient’s associations representa-
tives. In the context of suitability of chronic obstructive
disease (mainly COPD) management, three issues request-
ing greater attention were identified: the problem of a
more widespread and earlier diagnosis, the correct treat-
ment of acute and subacute phases of the disease, the ad-
equate assistance and monitoring of chronic patients. All
these topics were discussed in particular about needs and
priorities, actors, and competences.
Methods
The CC followed the procedure recommended by the
National Health Institute (ISS) for CC organization [23].
The Promoting Committee, i.e. the AIMAR Executive
Committee, appointed a technical-scientific committee
to identify the topics to be discussed in the three session
as above mentioned. Each session included a president,
responsible for the organization of the session, and a
streamleader charged with an updated revision of the
topic to be discussed and with the preparation, together
with an experts group, of few statements to be discussed
in each plenary session. In each session a group of dis-
cussants from different contexts (hospital and district
Figure 1 Results of voting of statement about the need of
spirometry for COPD diagnosis. A: results of first voting; B: results
of second voting.
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resentatives etc.) promoted the discussion of the state-
ments, and an independent jury similarly composed by
health professionals from various contexts, commented on
the results emerged from the different sessions of the con-
ferences and reviewed the document derived from these
results. With this structure more than one hundred per-
sons have been involved in the CC (Additional file 1). In
each session the streamleader first updated the audience
on the topic to be discussed, then he presented one at a
time the statements prepared for that session. Each state-
ment was then put to voting and each participant gave
his/her vote by an electronic system choosing one of the
different opinions reported in Table 1.
The statement was considered approved if the percent-
age of participants who voted “totally agree”, or the sum
of percentages of those who voted “total agree” and “very
much agree” was greater than 80%. Otherwise, the state-
ment was further analyzed and discussed and then voted
again: it was considered approved if the above conditions
were reached, otherwise it remained not approved.
Results and discussion
First session “The problem of diagnosis”
In a first statement it was affirmed that COPD diagnosis
cannot be performed without a spirometry test in order to
verify the presence and quantify the degree of bronchial
obstruction. A first voting did not yielded sufficient agree-
ment (Figure 1A), and the consequent discussion revealed
a too long waiting time for the examination to be done
and the cost of patient’s participation to the spirometric
test as negative factors impairing a more extensive use of
spirometry. A second voting reached the approval of the
statement (Figure 1B). During the discussion the fact that
some Italian regions established a target of spirometry im-
plementation in at least 90% of patients also emerged.
Most international guidelines and more recently the
document drawn up by Italian Scientific Respiratory
Societies together with an Association of Italian General
Practitioners, the National Agency for Health Services
and the Italian Health Ministry, all agree that COPD
diagnosis must be based on respiratory symptoms, risk
factors exposure, and demonstration of airflow obstruc-
tion with spirometry, together with other lung function
tests when necessary [7,19,24].Table 1 Graduation of opinions expressed on each
statement by participants
1) Totally agree
2) Very much agree
3) Partially disagree
4) Totally disagree
5) Don’t knowThe diagnostic characterization of COPD patients, aimed
to distinguish between prevalence of emphysema and
chronic bronchitis, has been agreed as desirable by the ma-
jority of participants (86%). In fact, in recent past these dif-
ferent disease entities have been grouped under the same
definition of COPD because they often coexist in the same
patients, especially when they are smokers, but they have
different physiologic consequences, induce a different de-
cline of respiratory function, and could likely take advan-
tage of different therapeutic approaches [25,26]. Based on
lung function (spirometry, lung mechanics and diffusion)
and radiographic investigations it is generally possible to
reveal the presence of either pathological entity and – to
some extent – quantify the relative importance when they
coexist [27]. The clinical value of diagnosing emphysema
resides in that lung hyperinflation, dyspnea and exertion
intolerance are predictors of poor survival independent of
level of airways obstruction. Besides, the severe hyperinfla-
tion often affects diastolic function of left ventricle and car-
diac output especially during exercise [28].
Looking at the compelling need of achieving a more
diffuse and earlier COPD diagnosis, another statement
pointed out that all smokers complaining of respiratory
symptoms should be addressed to a spirometry test and
this assertion was immediately accepted by 94% of vot-
ing people. This is in accordance with the diffuse view
that diagnosis should be based on a screening of symp-
tomatic subjects at risk rather than of general popula-
tion, where the screening would present a reduced cost/
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in general population and instead very high in smokers
aged over 40 years [29]. Such an approach is endorsed
by WHO in the GARD (Global Alliance for Chronic
Respiratory Disorders) document, where it is suggested
that each subject at risk should perform a spirometry
test [30]. General practitioner (GP) is charged with the
active search of new COPD patients by using suitable
questionnaires [31-33] allowing to find people poten-
tially affected with this disease. Long lasting cough and
expectoration, relapsing and hardly remitting infectious
episodes of airways, and above all the dyspnea out of
proportion in relation to effort or to individuals of the
same age, when present, should be interpreted by GP as
a need for further investigation with spirometry and/or
specialist’s consultation. In this respect the recent Italian
document on COPD management [7] recommends per-
forming a simple spirometry test (flow-volume curve) to
all subjects at risk and a global spirometry to those with
respiratory symptoms.
In order to further clarify the diagnosis in terms of
clinical and functional approach, another statement pre-
sented to discussion and voting supports that in subjects
with decreased lung volumes without obstruction other
investigations should be done to exclude restrictive dis-
eases like the neuromuscular ones, and it was approved
by more than 80% of participants. Restrictive diseases
are caused by decreased lung or chest wall compliance,
weakness of respiratory muscles, loss or collapse of lung
parenchyma, or by a combination of all the above alter-
ations. According to ERS-ATS guidelines [24] a restrict-
ive defect must be diagnosed only by the reduction of total
lung capacity (TLC) because vital capacity (VC) can be de-
creased by the parallel increase in residual volume (RV).
After excluding pulmonary or chest wall alterations, a
neuromuscular disease should be suspected and rapidly
diagnosed because in some cases (myasthenia, multiple or
disseminated sclerosis) useful treatments can be adopted
to support an incipient respiratory failure [34-36].
The last statement voted in this session was relative to
the need of a blood gas analysis to diagnose respiratory
failure to be treated with oxygen therapy and it was
agreed by the great majority of the attending people
(90%). Italian guidelines for long-term oxygen therapy
[7,37], recommend this treatment in patients with docu-
mented respiratory failure who present an arterial oxy-
gen pressure (PaO2) steadily ≤ 55 mmHg or borderline
hypoxemia (PaO2 56–60 mmHg) in presence of stable
polycythemia, pulmonary hypertension, tissue hypox-
emia, ischemic cardiomyopathy. Guidelines on diagno-
sis and treatment of stable COPD, published in 2011 by
American College of Physicians, American College of Chest
Physicians, American Thoracic Society, and European
Respiratory Society [38], recommend oxygen therapy alsowith Pulsoxymetric saturation (SpO2) < 88% based on the
opinion that pulse oximetry substantially superseded
blood gas analysis in outpatients. However, it is well
known that oximetry may yield inaccurate or erroneous
results in case of hemodynamic instability, presence of
carboxyhemoglobinemia, anemia, jaundice, and cutane-
ous pigmentation [39]. Even more important, oximetry
does not give any information about carbon dioxide
blood levels, and in case of hypoxemic-hypercapnic re-
spiratory failure oxygen therapy without ventilator sup-
port may aggravate the hypercapnia [40]. This is the
reason why the statement refers to Italian guidelines.
Second session “Management of acute/subacute stages”
The deleterious effects of acute exacerbations of COPD
(AECOPDs) on respiratory function, clinical symptoms
and outcome were first taken into account. In fact
AECOPDs, especially when they lead to hospital admis-
sion, negatively affect the course of COPD through re-
spiratory function deterioration, onset of cardiovascular
complications, skeletal muscles weakening, worsening
of quality of life, increased risk of relapses, hospital re-
admissions and mortality [41-43]. In this respect great
importance have some measures like promoting pa-
tient’s adherence to treatment, adequate drugs prescrip-
tion, programs of respiratory rehabilitation [44-46].
Thus, the first statement of this session concerned the
need for interventions aimed at decreasing the rate and
severity of AECOPDs as above indicated and it was
agreed by all voting persons (100%).
Some patients, because affected with AECOPD par-
ticularly severe or because they need particular treat-
ments not feasible at home or specialistic treatments
like noninvasive ventilation (NIV), have to be hospital-
ized [47,48]. In this context, particularly important is the
evaluation of whether and when to address the patient
to hospital admission. For this assessment, some princi-
ples have been identified that represent the matter of a
second statement: the decision to hospitalize one patient
should be based on the severity of symptoms, presence of
comorbidities, and degree of patient’s self-sufficiency at
home. Pulse oximetry is suitable to evaluate an exacer-
bated patient at home or at primary care level, whereas
the evaluation of an exacerbated patient at admission to
hospital should always include blood gas analysis, electro-
cardiogram, chest x-ray, laboratory examination (hemo-
chrome plus cytologic formula, electrolytes, theophylline
level, blood culture in case of fever). This statement was
accepted by 85% of participants.
The mortality of hospitalized patients may be increased
by some factors such as the development of respiratory
acidosis, the severity of dyspnea, and comorbidities. More-
over, frequent hospitalizations for AECOPD are associated
with a decreased survival in the mid and long-term
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third statement and the content of this statement was
agreed by the great majority of participants, while 10% of
them affirmed they did not know these problems.
As to pharmacologic treatment of AECOPDs, another
statement declared that: short-acting beta-2 agonist
bronchodilators (SABA) are generally preferred; further
studies are needed to verify the effectiveness of long-
acting beta-2 agonist (LABA) or antimuscarinic (LAMA)
bronchodilators, associated or not with inhaled cortico-
steroids (ICS); systemic corticosteroids induce a clinical
improvement, also when administered for less than 14 days
[54,55]; antibiotics are at present indicated in presence of
signs of bacterial infection (increased volume and puru-
lence of sputum), even if the positive influence on out-
come would be more evident in severe exacerbations
[56,57]. This statement raised a wide and lively discussion,
nevertheless the majority of attending people said they
only partially agreed (Figure 2), likely because this state-
ment deals with different pharmacological approaches,
that should be discussed singularly. Anyway they are based
on strong evidences in the literature also confirmed in
clinical practice.
Concerning the non pharmacologic treatment of
AECOPDs, a further statement affirmed that: oxygen
should be administered to all hypoxemic subjects with a
target SpO2 88-92%; high flow oxygen therapy is associ-
ated with a worse prognosis [58,59]; NIV should be
recommended in AECOPDs with ventilatory failure, be-
cause it can improve the outcome of severe exacerba-
tions [60,61], as demonstrated by its more diffuse use in
last decades [62-66]; respiratory rehabilitation is a safe
and effective treatment immediately after the acute epi-
sode, able to improve the outcome and decrease re-
admissions [45,46]. The statement was not approved,
probably for the same reasons expressed for the precedent
statement: in fact, while 76% of voting people agreed, 18%
admitted they did not know. Thus, a substantial agree-
ment about oxygen therapy and NIV was not reached ac-
cording to the pre-arranged criteria, but the participantsFigure 2 Results of voting of statement about pharmacologic
treatment of AECOPDs.saying they did not know these problems, and likely also
part of those who only partially agreed, definitely influ-
enced the negative results of voting.
Finally, the last statement of this session concerned
the assistance out of hospital and was based on the fol-
lowing assertions: the greater part of costs relative to
AECOPDs is determined by hospital admission and cor-
related with the clinical severity, with a large geograph-
ical variability, and linked to treatment protocols [67,68];
early discharge from hospital may be favored by the
presence of effective services of assistance at home. Se-
lected patients should be admitted to intermediate insti-
tutional health structures intermediate between hospital
and home, even if the advantages of these structures in
terms of treatment efficacy, patients preference and costs
still have to be defined [69-71]. The prevention and
prompt treatment of AECOPDs should be the main ob-
jective of primary care and an active intervention should
include the reduction of risk factors for AECOPDs (smok-
ing cessation, vaccination), inclusion in programs of re-
spiratory rehabilitation, individualized strategies for the
management of long-term control therapies [72-74]. All
the principles suggested in this last statement were ac-
cepted by the majority of voters, who recognized the im-
portance of preventing AECOPDs, especially at general
practice level, and reducing costs due to hospital admis-
sions through a shorter hospital stay and a more constant
and effective home assistance.
THIRD SESSION “Organizing the assistance to
chronic patients”
This session dealt with the present standards relative to
chronic respiratory patient’s care to define both oper-
ational aspects of long-term assistance and smoking ces-
sation, an intervention defined fundamental in scientific
literature and nevertheless widely disregarded in clinical
practice. In patients affected with COPD, smoking cessa-
tion may slow down both disability and death, and the pa-
tient who continues to smoke can be considered strongly
smoke-addict. Thus, smoking cessation is thought a crit-
ical therapeutic measure and this treatment must include
intensive intervention with pharmacologic and psycho-
behavioral therapy. Based on the data from literature and
guidelines, a first statement affirmed that active smoking
in respiratory patients is just a disease to be treated with
drugs and periodic assistance. In a first voting this state-
ment did not reach approval (75% agreed, 23% disagreed).
In the subsequent discussion some criticisms emerged
that impair a correct and comprehensive assistance to
smoker COPD patient: lack of well defined national stan-
dards and specific training of physicians and health
workers; lack of time to devote to smoking management;
no refundability of treatments. However, the opinion of
participants at the second voting did not substantially
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ing cessation has been found not only to slow down the
disease progression towards more severe stages and dis-
ability, but also to decrease mortality through its effect on
smoke-related comorbidities [6,75]. The minimal advice
afforded by physicians may result insufficient in strongly
nicotine-dependent smokers and a more intensive treat-
ment seems mandatory because a dose–response correl-
ation between intensity of intervention and its efficacy
has been demonstrated [76]. Unfortunately, in Italy
medical-assisted smoking cessation is not included in
basic principles of care, is not taught in universities, is a
voluntary-based practice, and the costs of treatment are
at patient’s expense.
To improve the patient-centered assistance to those
affected with COPD, a chronic disease with periods of
exacerbation and others of clinical stability, is strictly ne-
cessary that hospital and territory form a network to
guarantee the continuity of care and successfully treat
frequent comorbidities in chronic patients. There is no
clear definition of this network and of the precise re-
sponsibilities yet, and in a second statement it was
enounced that the responsible of forming a network for
health assistance of COPD patients is the respiratory
specialist. This statement was not accepted in this way
at first voting (Figure 3A) and a lively discussion took
place that evidenced a wide difference between Italian
regions or local places where there is a respiratory spe-
cialist for outpatients and those where there is not.Figure 3 Results of voting of statement about responsibility of
respiratory specialist for organizing a network of assistance to
COPD patients. A: results of first voting; B: results of second voting.Several attending physicians affirmed their difficulty to
form a similar network owing to their incompetence, to
lack of operational instruments and relative budget. The
statement was thus modified as follows: the respiratory
specialist is the coordinator of assistance activities for
COPD patients, and with this formulation it was ap-
proved (Figure 3B). It should be noted that also in this
case the criticisms are mainly attributable to NHS, be-
cause it still does not supply economic, logistic and in-
strumental resources (also in terms of communication
and information technology) to improve the interrela-
tionships among different specialists. Also the deficiency
of medical and nursing staff in pneumology units is at
the root of the poor enthusiasm to become responsible
of a network without human resources to do it.
To accomplish the continuity of care it is mandatory
that all who are involved share standardized interven-
tions based on the best evidences of institutional guide-
lines. In this context it has proposed the statement that
operational references should mainly be the institutional
national documents [6,7]. This statement was not ap-
proved (46% agreed, 55% disagreed) likely because – as
emerged from discussion – the best known guidelines
are those published by GOLD [19] and only a lower part
of voting people knew the national documents, even if
some of them pointed out that it is preferable, if not
mandatory, to refer to institutional national documents
because they are a guide not only for health workers but
also for administrators. A second voting did not reach the
approval again even if it substantially approached the
agreement (79% agreed, 16% disagreed). Further discus-
sion, with a clarification of the advantages inherent to the
use of guidelines adapted to national reality, led to a satis-
factory acceptance of the statement (83% agreed, 10% dis-
agreed). GOLD guidelines diffusion started more than one
decade ago and since not long ago they were the only ones
known in Italy, thus it is not surprising that the greatest
majority of physicians refer to them. This is confirmed by
another multicentric survey among general practitioners
[77] where 62% declared they refer to GOLD guidelines
and only 16% to institutional national guidelines, while
22% do not use guidelines at all. In the last two years,
however, both specialists and general practitioners
began to use institutional guidelines more and more,
also because these guidelines have been drawn up
through a collaboration of different medical and non-
medical components involved in respiratory assistance.
During the discussion many respiratory specialists also
expressed various criticism about the adequacy/inad-
equacy of GOLD guidelines to define the suitability of
COPD management, starting from the definition of
COPD itself, a common umbrella comprising very dif-
ferent clinical entities where recently the concept of
phenotype has been introduced. Thus, if on one hand
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a unique therapeutic solution, on the other hand there
is the need for separating different diseases with unlike
therapeutic approaches and outcomes. This induced in
last years GOLD committee to add complex diagrams,
not rarely open to criticism, in an attempt to depict a
more comprehensive image of the COPD patient previ-
ously restricted by the sole functional classification. In
this respect the discussion emphasized the innovative
and more adherent to real life management proposed by
the institutional national guidelines.
A controlled self-management may be very useful in a
chronic disease and the training of COPD patients for
this purpose seems really valuable. Another statement
just dealt with this important issue affirming that the
main reference to learn the self-management of COPD
is the Pneumology Unit and this statement was almost
unanimously accepted (91%). In fact, all the participants
to the conference recognized that the professional con-
tribution of all health workers in Pneumology Units is
the most qualified reference for patient’s education so as
Diabetology Units are for diabetic patients.
Integrated care and long-term monitoring out of hos-
pital are essential needs of a chronic disease like COPD.
Thus, it was presented for discussion the statement that
to accomplish these needs teleassistance is not indis-
pensable, but at first it was not agreed (73% agreed, 24%
disagreed). The discussion on this issue evidenced that
the negative form with which the statement had been
presented could have influenced the voting. Anyway, a
part from this consideration, the pessimistic result de-
rives from an honest realism based on the daily difficul-
ties generally encountered in recording and consulting
even banal clinical information, because most clinical
data frequently are hand-written, and this situation is
shared also by administrative structures. This also im-
plies that obtaining and studying epidemiological COPD
data is really difficult. A recent Italian study about the
main chronic diseases, comparing the prevalence data
coming from the administrative database with a sample
from general practitioners and with the ISTAT (Italian
Institute for Statistics) estimates, found a good correl-
ation among the different sources relatively to diabetes,
heart failure and ischemic cardiomyopathy, while there
was an underestimation of administrative data compared
to those from general practitioners [78] for respiratory
diseases, possibly due to a lower availability of manage-
ment tools in this field. However, the proposal of this
statement was useful to assess the different importance
attributed to ICT (Information and Communication
Technology) by respiratory specialists compared to other
professional operators, to point out again the incapacity
of NHS to timely supply ICT, the conspicuous differ-
ences regarding ICT endowment in various Italianregions or even in different districts of the same region,
and the lack of ICT instruments also in many hospitals.
After all these issues were discussed, the following vot-
ing approved the statement (84% agreed).
Finally, the participation of Pneumology Unit personnel
to the establishment and organization of intermediate
structures between hospital and territory for post-acute
COPD patients was dealt with in the last statement of this
session. This statement was not agreed (73% agreed, 26%
disagreed) and during the subsequent discussion some
perplexities rose relative to the almost absolute lack of
intermediate structures in our country, as well as to
chronic lack of medical and nursing personnel. In fact,
many voting participants pointed out that it is impossible
to discuss about programming and organizing the assist-
ance to post-acute patients, who sometimes request also
complex treatments, without logistic and human re-
sources. These reservations emerged so strong and evident
that, nevertheless the role of respiratory specialist in this
contest was clear to everybody, the percentage of those
who disagreed with the statement was even increased at
the second voting.
The last voting clearly demonstrated that the improve-
ment of care quality, while being a main task of health op-
erators, cannot outlook the administrative support, that is
the NHS. A study on the suitability of COPD management
performed in an Italian region already demonstrated that
the effort to improvement afforded by clinical health
personnel is not sufficient without the resources supported
by the NHS [79]. In a recent document [80] a respiratory
working group evidenced the responsibilities for COPD
management: the State and NHS are responsible for pro-
gramming (by allocating the relative funds) the most suit-
able preventive actions (some shared by all chronic
diseases) and integrating health services. Otherwise, neither
the good will of professionals can be sufficient.
Conclusions
The Third Consensus Conference in Respiratory Medicine
dealt with “technical” problems concerning COPD man-
agement also from a present and future organizational
point of view. Where guidelines are unequivocal or suffi-
ciently shared, or alternatively different guidelines propose
the same message, we did not find significant uncertain-
ties. Thus, it is not surprising that an easy agreement has
been reached about classical “issues”, so as that spirometry
is mandatory to make COPD diagnosis (while this opinion
is not always put into practice). Less expected seems that
diagnosis should first lead to definition of emphysema or
chronic bronchitis prevalence, and spirometry findings
have to be further investigated with a more complete func-
tional examination together with imaging data acquisition
if necessary. In fact, the prognostic implications and the
possible diversity of therapeutic approaches in the two
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diseases from those causing obstructive defects may be
present, make necessary that the specialists clarify the
most complex situations. The problem would instead be
relative to the technological, staff and budget resources
necessary to perform in-depth investigations or early diag-
nosis in all symptomatic smokers, whose appropriateness/
obligatoriness has been enthusiastically agreed.
The document proposed by the Italian respiratory so-
cieties together with a scientific society of general practi-
tioners with an institutional endorsement [7] proposes
simple spirometry to screen smokers and global spirom-
etry for symptomatic individual at risk. To put into prac-
tice these recommendations, scientific societies should
promote local trials, supported by the Health Ministry
and Regional Government, aimed at verifying feasibility,
effectiveness, and efficiency of different modalities of
screening with spirometry. In fact spirometry may be done
in different settings: by GP or his nurse in his surgery [81];
in the GP’s surgery by technicians made available by the
Pneumology Unit; by trained personnel in a pharmacy
[82]; in a structure of the Social and Health District.
There is a firm conviction that long-term oxygen ther-
apy should be based on repeated blood gas analyses. In
this context the task of scientific societies would be to
organize audit to verify the adherence not only of physi-
cians both to guidelines and to regional laws when present,
but also of patients to prescribed O2-therapy. In addition,
it seems appropriate that guidelines would include the
screening of active smoking in subjects prescribed long-
term oxygen therapy to intensively assist them to give up
smoking.
The second session of this conference resulted particu-
larly interesting because, differently from the first ses-
sion, it dealt with problems faced with other health
professionals besides the respiratory specialist. In fact,
the management of COPD patients, in addition to assist-
ance to smoking cessation, includes the monitoring of
disease outcome in order to adapt the treatment to the
real severity stage, and the education to a correct use of
inhalers, all accomplished by a working group of which
respiratory specialist is part [83].
In this session a moderate amount of “don’t know”
was recorded, that means a certain level of uncertainty
about the proposed criteria for hospitalization. The same
occurred as to factors that affect prognosis during and
after hospitalization of patients with AECOPDs. Prob-
ably, the acknowledgment not to know the problems
was mainly belonging to non pneumologists, so as the
opinion about pharmacologic and non-pharmacologic
treatments, that is issues of close specialist competence.
The last statement of the second session, dealing with
the assistance out of hospital, while agreed by the major-
ity of participants, showed however some perplexitiesderiving from the different regional situations in terms
of services supply.
The third session recorded the lower percentages of
agreement because some problem rose, as the doubts about
the reference documents and guidelines, the difficulties to
combine scientific evidences with organizational and clin-
ical issues, uncertainty on own role into the organization,
uncertainty/fragmentation of the organizational context,
lack of objective data.
AIMAR, in cooperation with other institutions and
scientific societies, is going to realize several initiatives
aimed at resolving doubts and uncertainties about who
does what and also at improving the collection of data.
Among these initiatives, three are particularly worthy,
also because they represent an answer to criticism
emerged in this CC.
The first one concerns a pneumologic network to
standardize the activities to be done on smokers with
respiratory morbidity and consists in: a) drawing up a
document of health policy summarizing the position and
responsibilities of respiratory specialists towards smoking
habit; b) implementation of an intervention protocol on
smokers in the context of respiratory medicine (according
to “asthma-like” model of ACCP); c) establishment of a
network of pneumology units active on smokers in ac-
cordance with the health policy document (point a) and
with the intervention protocol (point b) above mentioned;
d) accreditation of pneumology units of the network with
the endorsement of ISS Smoking, Alcohol and Drug Ob-
servatory (OSSFAD) through processes of internal and ex-
ternal audit by AIMAR and other scientific societies.
The second initiative is organized in cooperation with
a large-sized association of elderly people to define ex-
cellence requirements for pneumologists, GPs, pharma-
cists, patients and their care givers in the management
of chronic respiratory diseases.
The third initiative together with Health Federation and
Municipalities Association consists in preparing a sched-
ule to measure the suitability of COPD management.
The results of these initiatives and others in progress will
form the matter of discussion in the “Fourth Consensus
Conference in Respiratory Medicine”.Additional file
Additional file 1: Participants in Consensus Conference and relative
function.Competing interest
The authors declare that they have no competing interests.Authors’ contributions
All authors read and approved the final manuscript.
Sanguinetti et al. Multidisciplinary Respiratory Medicine 2014, 9:65 Page 9 of 11
http://www.mrmjournal.com/content/9/1/65Acknowledgment
Results of a Consensus Conference held in Rome, Italy, October 18-19, 2013.
Consensus Conference 2013 Group: Alimonti Pietro (AIMAR), Allegra Luigi
(AIMAR), Ambrosino Nicolino (AIMAR), Andò Filippo (AIMAR, University of
Messina), Battaglia Augusto (Regional Health Institution), Bellofiore Salvatore
(AIMAR), Bettoncelli Germano (SIMG), Bianchi Attilio (University of Salerno),
Borgia Rosa (Local Health Unit), Bruschelli Carla (SIMG), Camaioni Angelo
(S. Giovanni Addolorata Hospital), Carlone Stefano (AIMAR), Carraro Daniela
(Local Health Unit), Contiguglia Rosario (AIMAR), Coratella Giuseppe (AIMAR/
CARD), Dal Negro Roberto (AIMAR), De Benedetto Fernando (AIMAR), De
Martino Annamaria (Ministry of Health), Del Vecchio Mario (University of
Florence), Di Gregorio Antonio (AIMAR), Donner Claudio F (AIMAR), Fabiano
Franco (AIMAR), Fava Alba (Ministry of Health), Franchi Fausta (Associazione
Italiana Pazienti BPCO), Frateiacci Sandra (FEDERASMA), Gallelli Andrea (AIMAR),
Gentili Gilberto (CARD), Giovannini Waltere (Regional Health Institution), Grassi
Carlo (AIMAR), Gulotta Carlo (AIMAR), Infantino Antonio (SIICP), Iodice Francesco
(AIMAR), Isidori Pierpaolo (AIMAR), Langella Luigi (AIMAR), Laurendi Giovanna
(Ministry of Health), Ligia Gianpaolo (AIMAR), Luci Claudio (FEDERANZIANI),
Macchia Vincenzo (AIMAR), Marangio Emilio (AIMAR), Marasso Roberto (FIMMG),
Marinari Stefano (AIMAR), Marino Roberto (Regional Health Institution), Mazzilli
Lorenzo (Regional Health Institution), Melli Silvana (Local Health Unit), Mencacci
Claudio (SIP), Messina Roberto (FEDERANZIANI), Mondello Placido (G. Martino
Hospital), Morini Mara (CARD), Nardini Stefano (AIMAR), Neri Margherita (AIMAR),
Palange Paolo (AIMAR), Paneroni Mara (FSM), Parrino Liborio (University of
Parma), Pasqua Franco (AIMAR), Perillo Giuseppe (AIMAR), Pisanti Paola (Ministry
of Health), Pistelli Riccardo (Catholic University of Rome), Pistolesi Massimo
(AIMAR), Polverino Mario (AIMAR), Pozzi Giuseppe (FEDERANZIANI), Prestifilippo
Alessandro (FIMMG), Privitera Salvatore (AIMAR), Procaccini Rossana (FEDERASMA),
Proto Cesare (SICOA), Puglisi Giovanni (S. Camillo Forlanini Hospital), Rusticali Bruno
(AGE.NA.S.), Sagliocca Luciano (Regional Health Institution), Salemi Michelangelo
(AIMAR), Sanguinetti Claudio M (AIMAR), Selvi Eleonora (FEDERANZIANI), Sevieri
Gianfranco (AIMAR), Tangolo Domenico (O.I.R.M. Sant’Anna Hospital), Tempesta
Franco (Associazione Italiana Pazienti BPCO), Testa Angelo (SNAMI), Torchio
Roberto (AIMAR), Tramarin Roberto (SICOA), Tubaldi Alberto (AIMAR), Tupputi
Emmanuele (AIMAR), Vagheggini Guido (AIMAR), Valente Salvatore (Catholic
University of Rome), Vincenti Rigoletta (AIMAR), Vitacca Michele (AIMAR), Volpe
Gennaro (CARD), Zamparelli Paolo (AIMAR), Zanon Pietro (AIMAR).
Author details
1Managing Director Multidisciplinary Respiratory Disease, Senior Consultant
Respiratory Diseases, Quisisana Clinical Center, Rome, Italy, Rome, Italy.
2Center of Respiratory Weaning and Rehabilitation Auxilium Vitae, Volterra
(PI), Italy. 3Pneumology Unit, G.Martino General Hospital, Messina, Italy.
4Pneumology Unit, SS.Annunziata General Hospital, Chieti, Italy. 5Mondo
Medico, Multidisciplinary and Rehabilitation Outpatient Clinic, Borgomanero
(NO), Italy. 6Pneumology Unit, General Hospital, Vittorio Veneto (TV), Italy.
7High Specialty Provincial Pulmonologic Unit, “Scarlato” Hospital, Scafati (SA),
Italy. 8Lung Function and Sleep Unit, AOU S. Luigi, Orbassano (TO), Italy.
9Internal Medicine and Respiratory Diseases, Center of Respiratory Weaning
and Rehabilitation Auxilium Vitae, Volterra (PI), Italy. 10Scientific Secretariat,
AIMAR, Arona, (NO), Italy.
Received: 4 November 2014 Accepted: 28 November 2014
Published: 18 December 2014
References
1. Hunter DJ, Reddy KS: Noncommunicable diseases. N Engl J Med 2013,
369:1336–1343.
2. United Nations General Assembly: Political Declaration of the High-Level Meeting
of the General Assembly on the Prevention and Control of Non-Communicable
Diseases. 2011.
3. 65th World Health Assembly Closes With new Global Health Measures. Geneva:
World Health Association; 2012.
4. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M,
Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I,
Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM,
Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero
LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, et al: Disability-
adjusted life years (DALYs) for 291 diseases and injuries in 21 regions,
1990–2010: a systematic analysis for the global burden of disease study
2010. Lancet 2012, 380:2197–2223.5. Ministero della Salute: Relazione sullo Stato Sanitario della Popolazione 2011.
Roma: 2011.
6. Age.Na.S: Broncopneumopatia Cronica Ostruttiva. Linee Guida Nazionali di
Riferimento per la Prevenzione e la Terapia. Roma: 2010.
7. Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De
Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F,
Polverino M, Rossi A, Sanguinetti CM: The clinical and integrated
management of COPD. An official document of AIMAR (Interdisciplinary
Association for Research in Lung Disease), AIPO (Italian Association of
Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine),
SIMG (Italian Society of General Medicine). Multidiscip Resp Med 2014, 9:25.
8. Lucioni C, Donner CF, De Benedetto F, Lusuardi M, Mazzi S, Paggiaro PL,
Sanguinetti CM: I costi della broncopneumopatia cronica ostruttiva:
la fase prospettica dello studio ICE (Italian Costs for Exacerbations in
COPD). Pharmacoeconomics-Italian Res Articles 2005, 7:119–134.
9. Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF: Costs
of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO
study (social impact of respiratory integrated outcomes). Respir Med 2008,
102:92–101.
10. Bertella E, Zadra A, Vitacca M on behalf of General Practitioners Distretto 04
ASL 02 Brescia, Italy: COPD management in primary care: is an
educational plan for GPs useful? Multidiscip Resp Med 2013, 8:24.
11. van Weel C: Underdiagnosis of asthma and COPD: is the general
practitioner to blame? Monaldi Arch Chest Dis 2002, 57:65–68.
12. Van Schayck CP, Chavannes NH: Detection of asthma and chronic
obstructive pulmonary disease in primary care. Eur Respir J 2003, 39:16s–22s.
13. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive
pulmonary disease (COPD). Lancet 2004, 364:613–620.
14. Sutherland ER, Cherniack RM: Management of chronic obstructive
pulmonary disease. N Engl J Med 2004, 350:2689–2697.
15. Lusuardi M, Lucioni C, De Benedetto F, Mazzi S, Sanguinetti CM, Donner CF:
GOLD severity stratification and risk of hospitalization for COPD
exacerbations. Monaldi Arch Chest Dis 2008, 69:164–169.
16. Lyngsø AM, Gottlieb V, Backer V, Nybo B, Østergaard MS, Jørgensen HL,
Frolich A: Early detection of COPD in primary care; the Copenhagen
COPD screening project. COPD 2013, 10:208–215.
17. Caramori GB, Bettoncelli G, Tosatto R, Arpinelli F, Visonà G, Invernizzi G,
Novelletto BF, Papi A, Adcock IM, Ciaccia A: Underuse of spirometry by
general practitioners for the diagnosis of COPD in Italy. Monaldi Arch
Chest Dis 2005, 63:6–12.
18. Buffels J, Degryse J, Liistro G: Diagnostic certainty, co-morbidity and medi-
cation in a primary care population with presumed airway obstruction:
the DIDASCO2 study. Prim Care Respir J 2009, 18:34–40.
19. GOLD: Global Strategy for the Diagnosis, Management and Prevention of
COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2014.
http://www.goldcopd.org/.
20. World Health Organization: WHO Innovative Care for Chronic Conditions:
Building Blocks for Action: Global Report. Geneva: Executive Summary WHO
Library; 2002.
21. Donner CF, De Benedetto F, Sanguinetti CM: Conferenza di Consenso di
Roma, ottobre 2007: gli atti. Multidiscip Resp Med 2008, 3(2):105–162.
22. Donner CF, De Benedetto F, Sanguinetti CM, Nardini S: 2a Conferenza di
Consenso “Comportamenti condivisi in medicina respiratoria” Roma
28–31 maggio 2010: gli atti. Multidiscip Resp Med 2010, 5(5):320–382.
23. Istituto Superiore di Sanità: Come Organizzare una Conferenza di Consenso.
2009. http://www.snlg-iss.it.
24. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van
der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N,
McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative
strategies for lung function tests. Eur Respir J 2005, 26(5):948–968.
25. Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS: The
emphysematous and bronchial types of chronic airways obstruction. A
clinicopathological study of patients in London and Chicago.
Lancet 1966, 1(7442):830–835.
26. Miravitlles M, Soler-Cataluña JJ, Calle M, Soriano JB: Treatment of COPD by
clinical phenotypes: putting old evidence into clinical practice. Eur Respir
J 2013, 41(6):1252–1256.
27. Camiciottoli G, Bigazzi F, Paoletti M, Cestelli L, Lavorini F, Pistolesi M:
Pulmonary function and sputum characteristics predict computed
tomography phenotype and severity of COPD. Eur Respir J 2013,
42(3):626–635.
Sanguinetti et al. Multidisciplinary Respiratory Medicine 2014, 9:65 Page 10 of 11
http://www.mrmjournal.com/content/9/1/6528. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R,
Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE: Percent
emphysema, airflow obstruction, and impaired left ventricular filling. N
Engl J Med 2010, 362:217–227.
29. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ: Detecting
patients at a high risk of developing chronic obstructive pulmonary disease
in general practice: cross sectional case finding study. BMJ 2002, 324:1370.
30. http://www.who.int/gard/publications/GARD%20Book%202007.pdf.
31. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, COPD
Questionnaire Study Group: Scoring system and clinical application of
COPD diagnostic questionnaires. Chest 2006, 129:1531–1539.
32. van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D:
Comparison of existing symptom-based questionnaires for identifying
COPD in the general practice setting. Respirology 2005, 10:323–333.
33. Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D'Eletto T, Cote
C, Hawkins C, Phillips AL, COPD-PS Clinician Working Group: Development
and initial validation of a self-scored COPD population screener
questionnaire (COPD-PS). COPD 2008, 5(2):85–95.
34. Farrero E, Prats E, Povedano M, Martinez-Matos JA, Manresa F, Escarrabill J:
Survival in amyotrophic lateral sclerosis with home mechanical
ventilation: the impact of systematic respiratory assessment and bulbar
involvement. Chest 2005, 127:2132–2138.
35. Bach JR, Chaudhry SS: Standards of care in MDA clinics. Muscular
Dystrophy Association. Am J Phys Med Rehabil 2000, 79:193–196.
36. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD:
Morbidity and mortality associated with the restrictive spirometric
pattern: a longitudinal study. Thorax 2010, 65:499–504.
37. Linee Guida per la Ossigenoterapia a Lungo Termine (OTLT):
Aggiornamento AIPO anno 2004. Rass Pat App Resp 2004, 19:206–219.
38. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T,
Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R,
Shekelle P, American College of Physicians; American College of Chest
Physicians; American Thoracic Society; European Respiratory Society:
Diagnosis and management of stable chronic obstructive pulmonary
disease: a clinical practice guideline update from the American College of
Physicians, American College of Chest Physicians, American Thoracic Society,
and European Respiratory Society. Ann Intern Med 2011, 155:179–191.
39. Muñoz X, Torres FG, Sampol G, Rios J, Martí S, Escrich E: Accuracy and
reliability of pulse oximetry at different arterial carbon dioxide pressure
levels. Eur Respir J 2008, 32:1053–1059.
40. Hampson NB: Pulse oximetry in severe carbon monoxide poisoning.
Chest 1998, 114:1036–1041.
41. Guidelines NICE: Management of exacerbations of COPD. Thorax 2004,
59:i131–i156.
42. NICE Guidelines: CG101 Chronic obstructive pulmonary disease (update).
In 2010. http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf.
43. Chenna PR, Mannino DM: Outcomes of severe COPD exacerbations
requiring hospitalization. Semin Respir Crit Care Med 2010, 31:286–294.
44. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes
PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-
Roisin R: Global strategy for the diagnosis, management, and prevention
of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med 2013, 187:347–365.
45. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone
M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S,
MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J,
Rochester C, Schols A, Singh S, Troosters T, ATS/ERS Pulmonary
Rehabilitation Writing Committee: American Thoracic Society/European
Respiratory Society statement on pulmonary rehabilitation. Am J Respir
Crit Care Med 2006, 173:1390–1413.
46. Bolton CE, Bevan-Smith EF, Blakey JD JD, Crowe P, Elkin SL, Garrod R, Greening
NG, Heslop K, Hull JH, Man WDC, Morgan MD, Proud D, Roberts CM, Sewell L,
Singh SJ, Walker PP, Walmsley S, British thoracic society pulmonary
rehabilitation guideline development group, on behalf of the British thoracic
society standards of care committee: British Thoracic Society guideline on
pulmonary rehabilitation in adults. Thorax 2013, 68:ii1–ii30.
47. Garcia-Gutierrez S, Quintana JM, Barrio I, Bare M, Fernandez N, Vidal S,
Gonzalez N, Lafuente I, Arteta E, Esteban C, Pulido E, IRYSS-COPD
Appropriateness Study (IRYSS-CAS) group: Application of appropriateness
criteria for hospitalization in COPD exacerbation. Intern Emerg Med 2013,
8:349–357.48. García-Sanz MT, Pol-Balado C, Abellás C, Cánive-Gómez JC, Antón-Sanmartin
D, González-Barcala FJ: Factors associated with hospital admission in
patients reaching the emergency department with COPD exacerbation.
Multidiscip Respir Med 2012, 7:6.
49. Slenter RH, Sprooten RT, Kotz D, Wesseling G, Wouters EF, Rohde GG:
Predictors of 1-year mortality at hospital admission for acute exacerbations
of chronic obstructive pulmonary disease. Respiration 2013, 85:15–26.
50. Steer J, Gibson J, Bourke SC: The DECAF Score: predicting hospital
mortality in exacerbations of chronic obstructive pulmonary disease.
Thorax 2012, 67:970–976.
51. Suissa S, Dell'Aniello S, Ernst P: Long-term natural history of chronic
obstructive pulmonary disease: severe exacerbations and mortality.
Thorax 2012, 67:957–963.
52. Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrús A, Torres A, Miravitlles M:
Predictors of adverse outcome in patients hospitalised for exacerbation of
chronic obstructive pulmonary disease. Respiration 2012, 84:17–26.
53. HajaMydin H, Murphy S, Clague H, Sridharan K, Taylor IK: Anemia and
performance status as prognostic markers in acute hypercapnic
respiratory failure due to chronic obstructive pulmonary disease. Int J
Chron Obstruct Pulmon Dis 2013, 8:151–157.
54. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring
U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Müller B, Scherr A,
Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J:
Short-term vs conventional glucocorticoid therapy in acute
exacerbations of chronic obstructive pulmonary disease: the REDUCE
randomized clinical trial. JAMA 2013, 309(21):2223–2231.
55. Cheng T, Gong Y, Guo Y, Cheng Q, Zhou M, Shi G, Wan H: Systemic
corticosteroid for COPD exacerbations, whether the higher dose is better?
A meta-analysis of randomized controlled trials. Clin Respir J 2013, 7:305–318.
56. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T,
Torres A, van der Heijden G, Verheij TJ, European Respiratory Society;
European Society of Clinical Microbiology and Infectious Diseases:
Guidelines for the management of adult lower respiratory tract
infections. Eur Respir J 2005, 26:1138–1180.
57. Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA:
Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev 2012, 12:CD010257.
58. Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R: Effect of high flow
oxygen on mortality in chronic obstructive pulmonary disease patients in
prehospital setting: randomised controlled trial. BMJ 2010, 341:c5462.
59. Wijesinghe M, Perrin K, Healy B, Hart K, Clay J, Weatherall M, Beasley R:
Pre-hospital oxygen therapy in acute exacerbations of chronic
obstructive pulmonary disease. Intern Med J 2011, 41:618–622.
60. Ambrosino N, Vagheggini G: Noninvasive positive pressure ventilation in
the acute care setting: where are we? Eur Respir J 2008, 31:874–886.
61. Ambrosino N, Vagheggini G: Non-invasive ventilation in exacerbations of
COPD. Int J Chron Obstruct Pulmon Dis 2007, 2:471–476.
62. Williams JW, Cox CE, Hargett CW, Gilstrap DL, Castillo CE, Govert JA, Lugogo
NL, Coeytaux RR, McCrory DC, Hasselblad V, McBroom AJ, Posey R, Gray R,
Sanders GD: Noninvasive Positive-Pressure Ventilation (NPPV) for Acute
Respiratory Failure [Internet]. In Comparative Effectiveness Reviews, No. 68.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2012.
http://www.ncbi.nlm.nih.gov/books/NBK99179/.
63. Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA,
Mannino D, Sciurba FC, Holguín F: Outcomes of noninvasive ventilation
for acute exacerbations of chronic obstructive pulmonary disease in the
United States, 1998–2008. Am J Respir Crit Care Med 2012, 185:152–159.
64. Roberts CM, Stone RA, Buckingham RJ, Pursey NA, Lowe D, National Chronic
Obstructive Pulmonary Disease Resources and Outcomes Project
implementation group: Acidosis, non-invasive ventilation and mortality in
hospitalised COPD exacerbations. Thorax 2011, 66:43–48.
65. Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ: Nocturnal
non-invasive positive pressure ventilation for stable chronic obstructive
pulmonary disease. Cochrane Database Syst Rev 2013, 6:CD002878.
66. Dres M, Tran TC, Aegerter P, Rabbat A, Guidet B, Huchon G, Roche N; on
behalf of the CUB-REA Group: Influence of ICU case-volume on the
management and hospital outcomes of acute exacerbations of chronic
obstructive pulmonary disease*. Crit Care Med 2013, 41:1884–1892.
67. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH: Acute exacerbations of
COPD in the United States: inpatient burden and predictors of costs and
mortality. COPD 2012, 9:131–141.
Sanguinetti et al. Multidisciplinary Respiratory Medicine 2014, 9:65 Page 11 of 11
http://www.mrmjournal.com/content/9/1/6568. Yawn BP, Thomashow B: Management of patients during and after
exacerbations of chronic obstructive pulmonary disease: the role of
primary care physicians. Int J Gen Med 2011, 4:665–676.
69. Goossens LM, Utens CM, Smeenk FW, van Schayck OC, van Vliet M, van
Litsenburg W, Braken MW, Rutten-van Mölken MP: Cost-effectiveness of
early assisted discharge for COPD exacerbations in the Netherlands.
Value Health 2013, 16:517–528.
70. Utens CM, Goossens LM, Smeenk FW, Rutten Van Mölken MP, Van Vliet M,
Braken MW, Van Eijsden LM, VanSchayck OC: Early assisted discharge with
generic community nursing for chronic obstructive pulmonary disease
exacerbations: results of a randomised controlled trial. BMJ Open 2012, 16,2:.
71. Jeppesen E, Brurberg KG, Vist GE, Wedzicha JA, Wright JJ, Greenstone M,
Walters JA: Hospital at home for acute exacerbations of chronic obstructive
pulmonary disease. Cochrane Database Syst Rev 2012, 5:CD003573.
72. Ambrosino N, Janah N, Vagheggini G: Physiotherapy in critically ill
patients. Rev Port Pneumol 2011, 17:283–238.
73. Eaton T, Young P, Fergusson W, Moodie L, Zeng I, O'Kane F, Good N, Rhodes L,
Poole P, Kolbe J: Does early pulmonary rehabilitation reduce acute
health-care utilization in COPD patients admitted with an exacerbation? A
randomized controlled study. Respirology 2009, 14:230–238.
74. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J:
Pulmonary rehabilitation following exacerbations of chronic obstructive
pulmonary disease. Cochrane Database Syst Rev 2011, 10:CD005305.
75. Tønnesen P, Carrozzi L, Fagerstroem KO, Gratziou C, Jimenez-Ruiz C, Nardini
S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R: Smoking cessation in
patients with respiratory diseases: a high priority, integral component of
therapy. Eur Respir J 2007, 29:390–417.
76. Fiore M, Jaen CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, Dorfman SF,
Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh
HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD,
Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME,
Murray EW, Bennett G, Heishman S, Husten C, Morgan G, Williams C, et al:
Treating tobacco use and dependence: 2008 update: U.S. Public health
service clinical practice guideline executive summary. Respir Care 2008,
53:1217–1222.
77. Sanguinetti CM, De Benedetto F, Donner CF, Nardini S, Visconti A:
Pneumocafé project: an inquiry on current COPD diagnosis and
management among General Practitioners in Italy through a novel tool
for professional education. Multidiscip Resp Med 2014, 9:35.
78. Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S,
Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani
M, Sturkenboom MC, Schuemie MJ: Chronic disease prevalence from
Italian administrative databases in the VALORE project: a validation
through comparison of population estimates with general practice
databases and national survey. BMC Public Health 2013, 13:15.
79. Nardini S, Cicchitto G, De Benedetto F, Donner CF, Polverino M, Sanguinetti CM,
Visconti A, on behalf of The ALT-BPCO Group: Audit of the appropriateness of
integrated COPD management: the "ALT-BPCO" project. Multidiscip Resp Med
2014, 9:40.
80. Nardini S, Annesi-Maesano I, Del Donno M, Delucchi M, Bettoncelli G,
Lamberti V, Patera C, Polverino M, Russo A, Santoriello C, Soverina P: The
AIMAR recommendations for early diagnosis of chronic obstructive
respiratory disease based on the WHO/GARD model. Multidiscip Resp Med
2014, 9:46.
81. Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P,
Donner CF: A randomized controlled trial on office spirometry in asthma
and COPD in standard general practice: data from spirometry in Asthma
and COPD: a comparative evaluation Italian study. Chest 2006, 129:844–852.
82. Cawley MJ, Moon J, Reinhold J, Willey VJ, Warning Ii WJ: Spirometry: tool
for pharmacy practitioners to expand direct patient care services. J Am
Pharm Assoc 2013, 53:307–315.
83. Fromer L: Diagnosing and treating COPD: understanding the challenges
and finding solutions. Inter J Gen Med 2011, 4:729–739.
doi:10.1186/2049-6958-9-65
Cite this article as: Sanguinetti et al.: Standards of suitability for the
management of chronic obstructive respiratory diseases. Multidisciplinary
Respiratory Medicine 2014 9:65.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
